Injectable testosterone undecanoate for the treatment of hypogonadism.
about
Testosterone Replacement Therapy and Cardiovascular Risk: A ReviewThe pharmacotherapy of male hypogonadism besides androgens.Testosterone and obesity.Acute endothelial response to testosterone gel administration in men with severe hypogonadism and its relationship to androgen receptor polymorphism: a pilot study.Testosterone supplementation and body composition: results from a meta-analysis of observational studies.First-generation phosphodiesterase type 5 inhibitors dropout: a comprehensive review and meta-analysis.UK policy statements on testosterone deficiencyTestosterone Replacement Therapy: Long-Term Safety and Efficacy.Effectiveness and tolerability of parenteral testosterone undecanoate: a post-marketing surveillance study.Effect of testosterone supplementation on nitroso-redox imbalance, cardiac metabolism markers, and S100 proteins expression in the heart of castrated male rats.Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy.The practical management of testosterone deficiency in men.The safety of available treatments of male hypogonadism in organic and functional hypogonadism.Does testosterone supplementation increase PDE5-inhibitor responses in difficult-to-treat erectile dysfunction patients?Therapist-Assisted Progressive Resistance Training, Protein Supplements, and Testosterone Injections in Frail Older Men with Testosterone Deficiency: Protocol for a Randomized Placebo-Controlled Trial.
P2860
Q26771771-4FD72A95-E750-4CEC-B8DD-FB66F1EDCE4EQ38293550-6C82AE33-1C94-4029-9479-2AC8984AB9B9Q38485746-A5844158-4B65-4612-A8E3-F6ED96B8BF75Q38572040-A75ACBC6-3ACF-4C4D-B79C-D60FE5370154Q38848541-3FD93DEF-E9C1-4221-915E-A5F49CF02620Q38956366-B0D27A61-CCBE-42FC-BF67-6587703769F7Q39187384-3A791E9A-91FE-4425-BA4D-550C3F133932Q39302080-5A4D837F-C779-4D6C-BD57-E3C576651A34Q40496295-E943F486-0CDF-4BDA-AF89-771238F774A5Q46926157-9D556CFF-5337-4B5C-B3ED-B71D391DACDFQ47243697-C108D9ED-FC6A-4C74-A544-2987E99E8565Q48072729-BEACF8DD-B731-483B-82A2-3E71E3873E2EQ50046284-9FB1F02F-C7BD-4577-9D87-E3822FCD1746Q53621752-E33052E6-906E-4C5F-8255-677BDDE9B809Q53704952-4518D374-6276-4C43-B811-9213B6E6E420
P2860
Injectable testosterone undecanoate for the treatment of hypogonadism.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Injectable testosterone undecanoate for the treatment of hypogonadism.
@en
type
label
Injectable testosterone undecanoate for the treatment of hypogonadism.
@en
prefLabel
Injectable testosterone undecanoate for the treatment of hypogonadism.
@en
P2860
P1476
Injectable testosterone undecanoate for the treatment of hypogonadism.
@en
P2093
Elisa Maseroli
P2860
P304
P356
10.1517/14656566.2014.944896
P407
P577
2014-07-31T00:00:00Z